Michael Meyers

Michael Meyers

Corporate Officer/Principal at
Janssen Research & Development LLC
76 year
Health Technology
Health Services
Consumer Services

Profile

Michael L.
Meyers
is Vice President at Janssen Research & Development LLC.
Former roles include Independent Director at Nuvalent, Inc. from 2022 to 2026, Vice President-GU Oncology & Compound at Johnson & Johnson, Chief Medical Officer & Senior Vice President at Syndax Pharmaceuticals, Inc. from 2016 to 2022, Member at Memorial Sloan Kettering Cancer Center, Vice President-Oncology Scientific Innovation at Johnson & Johnson Innovation LLC, and Chief Medical Officer at Flare Therapeutics, Inc. from 2023 to 2026.
Education includes a doctorate from Albert Einstein College of Medicine, Inc.

Michael Meyers active positions

CompaniesPositionStart
Corporate Officer/Principal -

Former positions of Michael Meyers

CompaniesPositionEnd
NUVALENT, INC. Director/Board Member 2026-07-14
Chief Tech/Sci/R&D Officer 2026-01-30
SYNDAX PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2022-02-28
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Michael Meyers's experience

Training of Michael Meyers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Services

Consumer Services

Commercial Services

Health Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Meyers
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!